Background: Leishmaniasis is a widespread skin protozoan infectious disease. It is an
intracellular parasitic microorganism that develops in the body of infected female …

Zoonotic cutaneous leishmaniasis due to Leishmania major is a serious public health
problem in Algeria. On average, 10,000 new cases are reported every year among the 15 …

Objective To assess the epidemiological and chemotherapeutic aspects of cutaneous
leishmaniasis. Methods This study was carried out during September, 2011 to December …

Background: Cutaneous leishmaniasis (CL), endemic in Guatemala, mostly affects poor
people living in the northern region. A national control program that includes surveillance …

Both visceral and cutaneous leishmaniasis are endemic in East Africa. Visceral
leishmaniasis (VL) is caused predominantly by infection with Leishmania donovani. It is …

: Background: Annual report of Cutaneous Leishmaniasis (CL) is around 20-40 per 100000
and the numbers are on the rise. One of the areas where significant numbers of people are …

Cutaneous leishmaniasis (CL), caused by an obligate intracellular protozoan parasite from
the genus Leishmania, imposing a significant burden on underdeveloped countries …

Although non-fatal and mostly self-healing in the case of Leishmania (L.) major, cutaneous
leishmaniasis (CL) is mainly treated to reduce lesion healing time. Less attention is paid to …

The parasitic disease leishmaniasis is caused by protozoa of the genus Leishmania which
are transmitted by sand fly vectors of the genus Phlebotomus in the Old World and …

Objective The incidence of cutaneous leishmaniasis (CL) caused by Leishmania major has
increased in Morocco over the last decade, prompting the Ministry of Health to take …